MOUNTAIN VIEW, Calif., Jan. 18, 2011 /PRNewswire/ — Hotspur
Technologies, Inc. announced today that Dr. Greg Sampognaro,
Interventional Cardiologist at P & S Surgical Hospital in
Monroe, Louisiana, successfully completed the first use of the
GPSCath™ Balloon Dilatation Catheter in an intervention to
treat a blocked peripheral artery. Successful use of the
GPSCath Catheter in this type of procedure confirms the ability of
this device to assist patients who suffer from peripheral arterial
disease (PAD).
Hotspur’s GPSCath Catheter, a two-in-one device that performs
high-pressure angioplasty with a semi-compliant balloon, while also
offering the ability to inject physician-specified fluids through
Hotspur’s proprietary VisioValve™ injection system, has
already been commercially used in dialysis access procedures.
However, this expanded utilization of the device shows
Hotspur’s ability to target additional markets with devices that
are already commercially available, while working within the
devices’ indications for use.
During the procedure, Dr. Sampognaro utilized a 6mm GPSCath
balloon to cross and successfully dilate two high-grade stenoses in
the patient’s distal superficial femoral artery. After this
balloon inflation, the VisioValve system on the balloon was opened,
and an angiogram was performed to assess the angioplasty results
without requiring removal of the balloon or adjustment of the
guidewire. After subsequently placing a stent to treat the
remaining blockage, Dr. Sampognaro reinserted the GPSCath balloon
to further expand the stent before again utilizing the balloon’s
VisioValve system to inject contrast to perform the case’s final
angiogram.
“The ability to inject contrast through the catheter without
having to remove the balloon from the artery or adjust the wire
saved a lot of time, produced excellent contrast injection quality,
and simplified the procedure overall,” said Dr. Sampognaro.
&
‘/>”/>
